Investment Analysts’ updated eps estimates for Tuesday, November 25th: Acrivon Therapeutics (NASDAQ:ACRV) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $19.00 price target on the stock. accesso Technology Group (LON:ACSO) had its add rating reissued by analysts at Peel Hunt. The firm currently has a GBX 435 price [...]
Investment Analysts’ Updated EPS Estimates for November 25th (ACRV, ACSO, ADTN, AEO, AET, AMZN, ANF, AO, ASML, AVB)
